Ankita Durge

Ms. Ankita Durge

Symbiosis School of Biological Sciences, Pune, Mahārāshtra, International
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2023 in Food Hydrocolloids
Verified
Journal Article
Closed access
CBChaitra R. Bandiwadekar
Chaitra R. Bandiwadekar
AJAshwini D. Jagdale
Ashwini D. Jagdale
ADAnkita Durge
Ankita Durge
TPTejaswini A. Pachpor
Tejaswini A. Pachpor
RTRashmi Tupe
Rashmi Tupe

19 October 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
ADAnkita Durge
Ankita Durge
Isha SharmaIsha Sharma
Isha Sharma
RTRashmi Tupe
Rashmi Tupe
The glycation of various biomolecules is the root cause of many pathological conditions associated with diabetic nephropathy and end-stage kidney disease. Glycation imbalances metabolism and increases renal cell injury. Numerous therapeutic measures have narrowed down the adverse effects of endogenous glycation, but efficient and potent measures are miles away. Recent advances in the identification and characterization of noncoding RNAs, especially the long noncoding RNAs (lncRNAs), have opened a mammon of new biology to explore the mitigations for glycation-associated diabetic nephropathy. Furthermore, tissue-specific distribution and condition-specific expression make lncRNA a promising key for second-generation therapeutic interventions. Though the techniques to identify and exemplify noncoding RNAs are rapidly evolving, the lncRNA study encounters multiple methodological constraints. This review will discuss lncRNAs and their possible involvement in glycation and advanced glycation end products (AGEs) signaling pathways. We further highlight the possible approaches for lncRNA-based therapeutics and their working mechanism for perturbing glycation and conclude our review with lncRNAs biology-related future opportunities.